Skip to Content

Cantech Holding Inc BSSP

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BSSP is trading at a 3% premium.
Price
$0.00
Fair Value
$7.78
Uncertainty
Extreme
1-Star Price
$8.76
5-Star Price
$1.15
Economic Moat
Qblbkrw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BSSP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$371.89
Volume/Avg
1.9 Mil / 1.8 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company’s product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
1

Valuation

Metric
BSSP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BSSP
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
−2.35
Quick Ratio
BSSP

Profitability

Metric
BSSP
Return on Assets (Normalized)
−2,927.99%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
BSSP
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRMmxfbkbzxgLzk$570.1 Bil
VRTX
Vertex Pharmaceuticals IncMzlfjxczPsppj$108.0 Bil
REGN
Regeneron Pharmaceuticals IncCwnylfswNgnnc$105.6 Bil
MRNA
Moderna IncWwczpqkQyxvr$40.8 Bil
ARGX
argenx SE ADRRylfmndBwd$23.5 Bil
BNTX
BioNTech SE ADRMmrjwgglcSkkb$21.9 Bil
ALNY
Alnylam Pharmaceuticals IncHnnhdngxwXwlxvd$18.8 Bil
BMRN
Biomarin Pharmaceutical IncZbhlbqhPqmqs$16.5 Bil
RPRX
Royalty Pharma PLC Class AHgjhzphmFznzdn$13.6 Bil
INCY
Incyte CorpJgblpzdmVkftvvr$12.8 Bil

Sponsor Center